Search Results - "Eggo, R."

Reconstructing disease outbreaks from genetic data: a graph approach by Jombart, T, Eggo, R M, Dodd, P J, Balloux, F

“…Epidemiology and public health planning will increasingly rely on the analysis of genetic sequence data. In particular, genetic data coupled with dates and…”
Get full text

Compositional modelling of immune response and virus transmission dynamics by Waites, W, Cavaliere, M, Danos, V, Datta, R, Eggo, R M, Hallett, T B, Manheim, D, Panovska-Griffiths, J, Russell, T W, Zarnitsyna, V I

“…Transmission models for infectious diseases are typically formulated in terms of dynamics between individuals or groups with processes such as disease…”
Get full text

Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone by Camacho, A, Eggo, R.M, Goeyvaerts, N, Vandebosch, A, Mogg, R, Funk, S, Kucharski, A.J, Watson, C.H, Vangeneugden, T, Edmunds, W.J

“…Highlights • Phase 3 vaccine trials are challenging to design in epidemics, such as Ebola. • A mechanistic transmission model allowed more accurate estimation…”
Get full text

Duration of Ebola virus RNA persistence in semen of survivors: population-level estimates and projections by Eggo, Rosalind M, Watson, Conall H, Camacho, Anton, Kucharski, Adam J, Funk, Sebastian, Edmunds, W John

“…Ebola virus can persist in semen after recovery, potentially for months, which may impact the duration of enhanced surveillance required after interruption of…”
Get full text

Compositional modelling of immune response and virus transmission dynamics by Waites, W., Cavaliere, M., Danos, V., Datta, R., Eggo, R., Hallett, T., Manheim, D., Panovska-Griffiths, J., Russell, T., Zarnitsyna, V.

“…Transmission models for infectious diseases are typically formulated in terms of dynamics between individuals or groups with processes such as disease…”
Get full text

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial by Swaray, Ibrahim, Luhn, Kerstin, Greenwood, Brian, Leigh, Bailah, Bockarie, E, James, N L, Kamara, A, Bangura, M S, Jalloh, H, Jalloh, A B, Kamara, I, Marrah, C, Kaimbay, R M, Marah, W S, Tengheh, J N, Turay, A S, Fornah, A, Sow, A, Swaray, E, Ade-Cole, T, Koroma, M, Sam, A, Scott, T, Sessie, T, Sunders, J-H C, Turay, S I-S, Gibson, L, Kowuor, D, Kamara, F J, Conteh, Y, Daramy, M L, Fofanah, O, Hanson, T F, Kamara, G M, Kamara, R T, Leigh, B, Greenwood, B, Deen, G F, Edmunds, J, Baiden, F, Tindanbil, D, Rogers, B T, Serry-Bangura, A, Swaray, I B, Bangura, A, Kamara, M M, Suma, F B, Murray, M, Manno, D, Cox, S, Howard, N, Snowden, E, Howard, K, Melton, N, Eggo, R, Pearson, C, Van Alst, M, Gaddah, A, Lowe, B, Kohn, B, Sheriff, O, Ajala, T W, Fangawa, J, Sesay, K, Charles, M K, Heroe, P C, Egoeh, S G, Alghali, N D, Bah, A, Cole, A C, Fofanah, K, Kabba, H U, Kabba, M, Koroma, S B, Sankoh, T, Wilhem, H, Ben-Rogers, Y, Swaray, I, Kamara, K, Sheku, M F, Akhigbe, I, Chami, N P, van Roey, K, Bosompem, S, Hilton, T, Borboh, P, Saquee, T M D, Fornah, J, Edem-Hotah, J, Fatorma, T, Bangura, S, Bonnie, E, Donaldson, A, Ndingi, S, Nyallay, L, Fakaba, P J, Vincent, W, Tengbeh, A, Callaghan, M, Enria, L

“…The Ebola epidemics in west Africa and the Democratic Republic of the Congo highlight an urgent need for safe and effective vaccines to prevent Ebola virus…”
Get full text

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial by Afolabi, Muhammed O, Swaray, Ibrahim, Foster, Julie, Luhn, Kerstin, Leigh, Bailah, Bockarie, E, James, N L, Kamara, A, Smout, E, Bangura, M S, Jalloh, H, Jalloh, A B, Kamara, I, Konteh, A, Marrah, C, Sesay, M T, Kaimbay, R M, Kain, D, Marah, W S, Tengheh, J N, Turay, A S, Fornah, A, Sesay, F, Sow, A, Swaray, E, Ade-Cole, T, Koroma, M, Sam, A, Scott, T, Sessie, T, Sunders, J-H C, Turay, S I-S, Gibson, L, Kowuor, D, Kamara, F J, Conteh, Y, Daramy, M L, Fofanah, O, Hanson, T F, Kamara, G M, Kamara, R T, Leigh, B, Greenwood, B, Deen, G F, Piot, P, Edmunds, J, Lees, S, Wilson, P, Owusu-Kyei, K, Stuart, J, Bah, O M, Swaray, I B, Kamara, M M, Gallagher, K, Cesay, M, Brown, J, Howard, K, Jendrossek, M, Offergeld, K, Van Ballaert, S, Roza, L, Liberi, T, Hafezi, H, Tuda, G O, Bangura, G, Kroma, M T, Pessima, A, Rogers, M, Foday Jr, S, Charles, M K, Lamin Karbo, M, Trye, A, Nambuchi, L, Jalloh, K F N, Jalloh, N, Kanjie, F, Kargbo, I, Sankoh, A, Williams, C T, Bangura, I, Ben-Rogers, Y, Kanawah, I, Kargbo, A T, Amara, L, Jakema, H B, Sheku, M F, Marrah, M, Moinina, E, Kalokoh, J, Hilton, T, Idriss, B, Sillah, M, Murray, T, Sannoh, M, Nyaberi, D, Vy, V, Fombah, A, Lahai, A, Yambasu, N, Bangura, M

“…Children account for a substantial proportion of cases and deaths from Ebola virus disease. We aimed to assess the safety and immunogenicity of a two-dose…”
Get full text

Global and national estimates of the number of healthcare workers at high risk of SARS-CoV-2 infection by McCarthy, C.V., Sandmann, F.G., Eggo, R.M., Knight, G.M., Flasche, S., Foss, A.M., Klepac, P., Jafari, Y., Waterlow, N.R., Meakin, S.R., Lei, J., Villabona-Arenas, C.J., Procter, S.R., Abbott, S., Funk, S., Bosse, N.I., O'Reilly, K., Waites, W., Abbas, K., Gimma, A., Showering, A., Jarvis, C.I., Kucharski, A.J., Endo, A., Jombart, T., Medley, G., Brady, O., Barnard, R.C., Williams, J., Davies, N.G., Edmunds, W.J., Munday, J.D., Pearson, C.A.B., Liu, Y., Atkins, K.E., Gibbs, H.P., Russell, T.W., Tully, D.C., Lowe, R., Clifford, S., Nightingale, E.S., Hellewell, J., Rosello, A., Quaife, M., Krauer, F., Desmond Chan, Y.-W., Sun, F.Y., van Zandvoort, K., Quilty, B.J., Koltai, M., Prem, K., Jit, M.

Get full text

Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries by Torres-Rueda, Sergio, Sweeney, Sedona, Bozzani, Fiammetta, Naylor, Nichola R, Baker, Tim, Pearson, Carl, Eggo, Rosalind, Procter, Simon R, Davies, Nicholas, Quaife, Matthew, Kitson, Nichola, Keogh-Brown, Marcus R, Jensen, Henning Tarp, Saadi, Nuru, Khan, Mishal, Huda, Maryam, Kairu, Angela, Zaidi, Raza, Barasa, Edwine, Jit, Mark, Vassall, Anna

“…ObjectivesCOVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting…”
Get full text

A39 Reconstruction of Ebola chains of transmission using sequence and epidemiological data by Robert, A, Edmunds, J, Eggo, R, Henao-Restrepo, A -M, Gsell, P -S, Watson, C H, Longini, I M, Rambaut, A, Camacho, A, Hué, S

“…Abstract Transmission trees can be established through detailed contact histories, statistical inference, phylogenetic inference, or a combination of methods…”
Get full text